Post-approval studies (Phase 4)Study completedNCT00495612
What this trial is testing
Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma
Who this might be right for
Asthma
Genentech, Inc. 69